Le Lézard
Classified in: Health
Subjects: WOM, CSR

The Pink Thread Project®: Lands' End Partners with the Breast Cancer Research Foundation (BCRF), Offering Three Ways to Donate


DODGEVILLE, Wis., Sept. 27, 2018 /PRNewswire/ -- Lands' End is raising awareness and funding for the Breast Cancer Research Foundation through the annual Pink Thread Project. From now through October 31, Lands' End offers three ways to donate to life-saving research. The campaign, in its fifth year, was created to further support the organization's mission to end breast cancer by advancing the world's most promising research.

Lands' End is raising awareness and funding for the Breast Cancer Research Foundation through the annual Pink Thread Project.

"We are proud to partner with the Breast Cancer Research Foundation. The Pink Thread Project ties together our five years of giving and once again demonstrates that a little pink truly does a lot of good," said Gill Hong, EVP, Chief Merchandising Officer and Head of International, Lands' End. "Our customers truly enjoy engaging in our donation efforts, whether through social media, adding a pink monogram, or shopping our Pink Thread collection. Together, we look forward to making a difference."

The Pink Thread Project is a simple, beautiful way to raise funds for breast cancer research. Shoppers choose how they want to give. Over the past four years, Lands' End has donated more than $282,000 to fund 5,600 hours of BCRF research to help bring an end to breast cancer.

Additional Ways to Make a Difference

"BCRF investigators around the world are working every day to eradicate breast cancer," said Myra J. Biblowit, BCRF president & CEO. "By supporting BCRF, Lands' End is making a real impact?improving outcomes and saving lives."

ABOUT LANDS' END, INC.
Lands' End, Inc. (NASDAQ: LE) is a leading multi-channel retailer of clothing, accessories, footwear and home products. We offer products through catalogs, online at www.landsend.com and affiliated specialty and international websites, and through retail locations. We are a classic American lifestyle brand with a passion for quality, legendary service and real value, and seek to deliver timeless style for men, women, kids and the home.

ABOUT BREAST CANCER RESEARCH FOUNDATION 
The Breast Cancer Research Foundation (BCRF) is dedicated to being the end of breast cancer by advancing the world's most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment and survivorship. This year, BCRF will award $63 million to support the work of more 300 scientists at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research worldwide. BCRF is the highest rated breast cancer organization in the U.S. Visit www.bcrf.org to learn more.

URLs: www.landsend.com/pinkthread
www.landsend.com/newsroom

 

(PRNewsfoto/Lands' End, Inc.)

SOURCE Lands' End, Inc.


These press releases may also interest you

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...



News published on and distributed by: